Hideo Arai
Director/Board Member at INA RESEARCH INC.
Net worth: 119 849 $ as of 2024-04-29
Profile
Hideo Arai currently works at Oriental Yeast Co., Ltd., as Director & General Manager-Bioindustry Business from 1981, Ina Research, Inc., as Outside Director from 2019, and Kohjin Bio Co., Ltd., as Independent Outside Director from 2015.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
Kohjin BIO Co., Ltd.
Kohjin BIO Co., Ltd. BiotechnologyHealth Technology Kohjin Bio Co., Ltd. engages in the manufacture and sale of animal blood, serums, tissue culture media and other products. It operates through the following business segments. Tissue Culture Business, Microbiology Business and Cell Processing Business. The Tissue Culture business segment engages in the manufactures, and sale of tissue culture media, including serum free media used for research purposes in regenerative medicine and immunotherapy. The Microbiology business segment develops, manufactures, and sells a wide variety of microorganism detection media used for pathogen testing in the clinical and food fields, and quality testing in various fields such as pharmaceuticals and cosmetics. The Cell Processing business segment conducts cell processing operations under contract from medical institutions. The company was founded by Takato Nakamura in April 1981 and is headquartered in Sakado, Japan. 0.20% | 2024-03-21 | 10,000 ( 0.20% ) | 119 849 $ | 2024-04-29 |
Hideo Arai active positions
Companies | Position | Start |
---|---|---|
INA RESEARCH INC. | Director/Board Member | 2019-05-31 |
Oriental Yeast Co., Ltd.
Oriental Yeast Co., Ltd. Food: Major DiversifiedConsumer Non-Durables Oriental Yeast Co., Ltd. engages in the manufacture and sale of yeast, raw materials for bread manufacturing, confectionery, noodles, various feeds, biochemistry, and toxicity studies on medicines, food, and others. It is also engages in sales of laboratory animals. Its operations are carried out through the following segments: Food Business and Bioindustry Business. The Food Business segment develops and supplies food ingredients including yeast, flour paste, and mayonnaise. The Bioindustry Business segment produces diagnostic reagent raw materials or reagent in research use, including recombinant enzymes and human proteins. The company was founded on June 30, 1929 and is headquartered in Tokyo, Japan. | Director/Board Member | 2011-04-27 |
Kohjin BIO Co., Ltd.
Kohjin BIO Co., Ltd. BiotechnologyHealth Technology Kohjin Bio Co., Ltd. engages in the manufacture and sale of animal blood, serums, tissue culture media and other products. It operates through the following business segments. Tissue Culture Business, Microbiology Business and Cell Processing Business. The Tissue Culture business segment engages in the manufactures, and sale of tissue culture media, including serum free media used for research purposes in regenerative medicine and immunotherapy. The Microbiology business segment develops, manufactures, and sells a wide variety of microorganism detection media used for pathogen testing in the clinical and food fields, and quality testing in various fields such as pharmaceuticals and cosmetics. The Cell Processing business segment conducts cell processing operations under contract from medical institutions. The company was founded by Takato Nakamura in April 1981 and is headquartered in Sakado, Japan. | Director/Board Member | 2015-05-31 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
Health Technology |
Private companies | 2 |
---|---|
Oriental Yeast Co., Ltd.
Oriental Yeast Co., Ltd. Food: Major DiversifiedConsumer Non-Durables Oriental Yeast Co., Ltd. engages in the manufacture and sale of yeast, raw materials for bread manufacturing, confectionery, noodles, various feeds, biochemistry, and toxicity studies on medicines, food, and others. It is also engages in sales of laboratory animals. Its operations are carried out through the following segments: Food Business and Bioindustry Business. The Food Business segment develops and supplies food ingredients including yeast, flour paste, and mayonnaise. The Bioindustry Business segment produces diagnostic reagent raw materials or reagent in research use, including recombinant enzymes and human proteins. The company was founded on June 30, 1929 and is headquartered in Tokyo, Japan. | Consumer Non-Durables |
Ina Research, Inc.
Ina Research, Inc. Miscellaneous Commercial ServicesCommercial Services Ina Research, Inc. engages in the development of pharmaceutical products. It operates through Entrusted Testing and Environment segments. The Entrusted Testing segment covers the safe testing of pharmaceuticals, medical equipment, pesticides, food, and other chemicals and also handles the commissioned clinical trials for drug development. The Environment segment designs and sells deodorizing equipment, sterilization device, and related laboratory equipment. The company was founded on July 13, 1974 and is headquartered in Ina, Japan. | Commercial Services |
- Stock Market
- Insiders
- Hideo Arai